Reckitt Benckiser Group (LON:RKT) Shares Up 0.2% – Still a Buy?

Reckitt Benckiser Group plc (LON:RKT) traded up 0.2% on Thursday . The stock traded as high as GBX 5,196 ($70.74) and last traded at GBX 5,162 ($70.28). 737,980 shares traded hands during trading, a decline of 83% from the average session volume of 4,263,184 shares. The stock had previously closed at GBX 5,150 ($70.12).

Reckitt Benckiser Group Price Performance

The business has a 50-day moving average of GBX 4,903.58 and a two-hundred day moving average of GBX 5,005.94. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The firm has a market cap of £35.22 billion, a P/E ratio of 23.62, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09.

Insider Transactions at Reckitt Benckiser Group

In related news, insider Kris Licht sold 3,799 shares of Reckitt Benckiser Group stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of GBX 5,177 ($70.48), for a total value of £196,674.23 ($267,766.14). Company insiders own 0.05% of the company’s stock.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.